COVID-19 Vaccine Precautions

COVID-19 Vaccine Precautions PDF download free from the direct link given below in the page.

6 Like this PDF
❴SHARE THIS PDF❵ FacebookX (Twitter)Whatsapp

COVID-19 Vaccine Precautions PDF

Pregnant and lactating women have not been a part of any COVID-19 vaccine clinical trial so far and should not receive the COVID-19 vaccine at this time, cautioned the Health Ministry in its note on precautions and contraindications for the vaccines. It added that vaccine-specific contraindications may apply as new information becomes available.

General Guidelines

  • The vaccination is only for people over the age of 18 years.
  • The vaccines are not interchangeable: the second dose will have to be of the same vaccine that was administered as the first dose.
  • The vaccine should be given with “caution” to persons with a history of any bleeding or coagulation disorder — platelet disorder, clotting factor deficiency, or coagulopathy.
  • Vaccinators have to store both vaccines at +2°C to +8°C; protect them from light; and discard the vaccine if found to be frozen.

The vaccine cannot be administered to people who belong to any of three categories:

  • Persons with a history of an allergic reaction to a previous dose of a Covid-19 vaccine (this would mean those who have taken a dose in a country where vaccination has already started);
  • People who show an immediate or delayed onset of an allergic reaction to vaccines or injectable therapies, pharmaceutical products, and food items;
  • Pregnant and lactating women. Since they have not been part of any clinical trial so far, women who are “pregnant or not sure of their pregnancy” and “lactating women” should not receive the vaccine at this time.

For certain circumstances under the category of temporary contraindications, vaccination is to be deferred for four-eight weeks after recovery. This covers three categories:

  • Persons showing active symptoms of SARS-CoV-2 infection
  • Covid-19 patients who have been given anti-SARS-Cov-2 monoclonal antibodies or convalescent plasma
  • Acutely unwell and hospitalised patients (with or without intensive care) due to any illness.

Two vaccines have been granted emergency use approval in India – Covishield, developed by Oxford University and AstraZeneca and produced by Serum Institute of India, and COVAXIN, developed and produced in India by Bharath Biotech.

You can download the COVID-19 Vaccine Precautions in PDF format using the link given below.

2nd Page of COVID-19 Vaccine Precautions PDF
COVID-19 Vaccine Precautions

Download COVID-19 Vaccine Precautions PDF

REPORT THISIf the purchase / download link of COVID-19 Vaccine Precautions PDF is not working or you feel any other problem with it, please REPORT IT by selecting the appropriate action such as copyright material / promotion content / link is broken etc. If this is a copyright material we will not be providing its PDF or any source for downloading at any cost.


  • Aatmanirbhar Bharat Rozgar Yojana

    Union Minister for Finance & Corporate Affairs Smt. Nirmala Sitharaman has announced 12 key measures, as part of Government of India’s stimulus to the economy, under AatmaNirbhar Bharat 3.0. The net stimulus announced today amounts to ₹ 2.65 Lakh crore. While addressing the Press Conference here today , SmtSitharaman also informed that...

  • AIDs Quiz Questions and Answers

    Acquired Immune Deficiency Syndrome (AIDS) is a disease caused by HIV. In that condition, a human’s immune system is too weak to protect against any sickness or infection. AIDS is usually the last stage of HIV infection when the patient can no longer defend himself and thus spreads various diseases....

  • Bharat Biotech Covaxin Fact Sheet

    COVAXIN – India’s First Indigenous COVID-19 Vaccine COVAXIN, India’s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3) high containment...

  • Budget 2021-22

    The Union Minister for Finance & Corporate Affairs, Smt Nirmala Sitharaman presented the Union Budget 2021-22 in Parliament today, which is the first budget of this new decade and also a digital one in the backdrop of unprecedented COVID-19 crisis. Laying a vision for Aatma Nirbhar Bharat, she said this...

  • Budget Highlights 2021

    Union Minister of Finance and Corporate Affairs Smt. Nirmala Sitharaman stated that India’s fight against COVID-19 continues into 2021 and that this moment in history, when the political, economic, and strategic relations in the post-COVID world are changing, is the dawn of a new era – one in which India is well-poised to truly...

  • COVID-19 Paragraph in 200 Words

    Hello, Friends today we are sharing with you the COVID-19 Paragraph in English 200 Words PDF to help you. If you are searching COVID-19 Paragraph in English 200 Words in PDF format then you have arrived at the right website and you can directly download it from the link given...

  • Covid-19 Vaccine Certificate

    This COVID-19 Vaccine certificate can be downloaded by anyone who has been vaccinated and this certificate can be obtained from the Cowin official website Here is the complete procedure for the Covid-19 Vaccine certificate PDF download. COVID-19 Vaccine Certificate Download PDF – How to Download Below is the complete...

  • COVID-19 Vaccines Operational Guidelines

    Coronavirus disease (COVID-19), is an infectious disease caused by a newly discovered coronavirus (SARS-CoV-2), which has spread rapidly throughout the world. In March 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic. The pandemic has severely ravaged health systems, and economic and social progress globally. In India,...

  • Covishield Vaccine Details

    This vaccine has been given a restricted use license for emergency situations. It does not have a marketing authorization, however, this approval for the restricted use in emergency situation grants permission for the vaccine to be used for active immunization of individuals aged 18 years and older for the prevention...

Leave a Reply

Your email address will not be published. Required fields are marked *